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Significantly higher (P<0-05) thrombin-antithrombin III 
complex levels were found in the abdominal exudate of 
patients with peritonitis (median 5500 ng/ml) than in that 
of controls (median 89 ng/ml). In patients, peritoneal fluid 
concentrations of tissue and urokinase-type plasminogen 
activator were increased by factors of 65 and 10 
respectively (P<0-05). The concentration of plasminogen 
activator inhibitor (PAI) 1 was increased by a factor of 
about 800 (median 395 versus 0-5 ng/ml, P<0-05). Despite
markedly raised concentrations of PAI, peritoneal fluid 
displayed fibrinolytic activity as demonstrated by 
significantly increased (P < 0 ’05) concentrations of 
plasmin-a2-antiplasmin complex (median 10 952 versus 
57 ng/ml) and fibrin degradation products (median 40 360 
versus 126 ng/ml). There was no correlation between 
plasma and peritoneal fluid concentrations. Intra­
abdominal coagulation and fibrinolysis are stimulated in 
the abdominal cavity of patients with bacterial peritonitis.
« ■ m m *
In bacterial peritonitis, fibrin is formed in the peritoneal
cavity as a r of activation of the intra-abdominal
coagulation cascade. Intraperitoneal fibrin plays a key role 
in the local host response to bacterial invasion, and 
prevents early bacteraemia and sepsis by entrapment of 
bacteria1. The role of fibrin is only temporary and fibrin 
must be degraded for normal tissue function to resume. 
When intra-abdominal fibrin persists, it acts as a nidus for 
infection, resulting in an intra-abdominal abscess2. In 
patients with bacterial peritonitis, intra-abdominal 
abscesses are associated with marked morbidity and 
mortality3,4.
For the degradation of intra-abdominal fibrin, stimu­
lation of the intraperitoneal fibrinolytic system is required. 
However, fibrinolytic activity is reduced during bacterial
peritonitis,
experimental
demonstrated in several
5 - 7 Diminished
plasminogen activator (tPA) and increased 
plasminogen activator inhibitor (PAI) from peritoneal 
tissue have been considered to be important reasons for 
the reduced fibrinolysis7. Recently, the authors have 
demonstrated an increase in both tPA and PAI activity in 
the abdominal exudate of rats with faecal peritonitis, but
this not correlate with the extent of
damage6. In patients with peritonitis, research has thus far
confined  to
p eriton eu m 8. T he aim o f  the present study was to assess  
coagulation  and fibrinolytic activity in the abdom inal
exudate and plasm a o f  patients with bacterial peritonitis.
Patients and m ethods
‘Sl<>
Ethical approval was obtained from the hospital ethics com­
mittee. Twenty-five patients who
laparotomy for peritonitis were studied. Peritonitis was due to 
perforated appendicitis in ten patients, duodenal perforation in 
five, perforated diverticulitis in five, small bowel perforation in 
two, toxic megacolon with perforation in two, 
ascites due to pancreatic necrosis in one. Abdominal cultures 
revealed bacterial growth in all patients. There were 16 male and 
nine female patients of mean age 48 (range 11 -9 0 )  years.
Paper accepted 27 November 1095
Seven patients undergoing elective cholecystectomy for gall­
stone disease served as controls (three men and four women, 
mean age 50 (range 12—75) years). Bacterial cultures of the 
peritoneal fluid were negative in all control patients. After 
incision and meticulous haemostasis, 10 ml of peritoneal fluid 
were aspirated from the abdominal cavity of all patients with 
peritonitis. In patients undergoing cholecystectomy, the amount 
of fluid aspirated varied between 0-5 and 2 ml, and was diluted 
with normal saline to a total amount of 10 ml.
Venous blood (10 ml) was drawn simultaneously with 
peritoneal fluid aspiration. Peritoneal fluid and 
collected in a citrate tube (1:10) and a Stabilyte (Biopool, 
Umea, Sweden) tube (1:10) respectively, and placed in melting 
ice'1. Within 30 min the samples were centrifuged at 4°C and 
supernatants stored at -  80°C until assays were performed.
Activation of coagulation was 
thrombin-antithrombin III (TAT) complex,
by measuring the
n
generation is the final step in the coagulation cascade before
tPA, urokinase-type
activator (uPA), PAI-1, plasmin-«2-antiplasmin (PAP) complex
and fibrin degradation products were measured.
Assays
The concentration of TAT complex was measured by enzyme- 
linked immunosorbent assav (ELISA)>en y
Behringwerke, Marburg, Germany).
of tPA a was measured by ELISA
tPA; Boehringer, Mannheim, many).
assay measures both free and complexed (with P A M ) human 
tPA and is calibrated against the international standard for tPA.
by Coaset-tPA assay (Kabi 
Diagnostic», Molndal, Sweden), as described by Nilsson et al. Iu.
-  I t!
HfHM %
Vr*r* by ELISA
. ItUmea, Sweden). The assay measures 
complexed (with tPA or uPA) human PAI-1. PAI activity was 
measured by Berichrom-PAI assay (Behringwerke), as described 
by Stief et a!,".
The level of uPA antigen in plasma and peritoneal fluid was 
measured by ELISA, according to the method of Binnema et 
al. '2. Concentrations were expressed as a percentage of the uP/ 
concentration in normal pooled plasma of healthy volunteers.
PAP complex was measured by ELISA (EIA APP mien 
Behringwerke). Fibrin degradation products were measured by
FbDP; Turnhout,
: va of the assays was not affected by the dilution of
peritoneal fluid in control patients.
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Table 1 Parameters of coagulation and fibrinolysis in the peritoneal fluid of patients with peritonitis and controls
Peritoneal fluid Peritonitis (n =  25) Controls* (n — 7)
tPA antigen (ng/ml) 66* 1 (37-5-180-0) 1-1 (0*5—l-8)t
tPA activity (units/ml) 6-5 (3-7-11 -9) <0-25 (< 0 -2 5 -0 -3 )t
PAI antigen (ng/ml) 395 (147-588) 0-5 ( < 0 - 5 - l - 3 ) t
PAI activity (units/ml) 14-3 (7-4-22-2) <0-3 ( < 0 - 3  to < 0-3 )t
uPA antigen (%) 740 (168-2000) 78 (14-168)t
TAT complex (ng/ml) 5500 (2976-9094) 89 (30-198)t
PAP complex (ng/ml) 10952 (4834-15469) 57 (17—123)f
Fibrin degradation products (ng/ml) 40360 (6475-200000) 126 (31-463)t
Values are median (95 per cent confidence interval). ’"Results corrected for dilution at sampling. tPA, Tissue-type plasminogen activator; 
PAI, plasminogen activator inhibitor; uPA, urokinase-type plasminogen activator; TAT, thrombin-antithrombin III; PAP, plasmin- 
a2-antiplasmin. f P <  0*05 (patients with peritonitis versus controls, Mann-Whitney U test)
Table 2 Parameters of coagulation and fibri 
of patients with peritonitis and controls
is in the plasma
Plasma
Peritonitis 
(n = 25 )
Controls 
(n =  7)
tPA antigen (ng/ml) 
tPA activity (units/ml) 
PAI antigen (ng/ml) 
PAI activity (units/ml) 
uPA antigen (%)
TAT complex (ng/ml) 
PAP complex (ng/ml) 
Fibrin degradation 
products (ng/ml)
7-9 (4-9-12-6) 
2-3 (1 -7-3-3) 
15-0 (10-2-22-3) 
1-7 (0-9-2-9) 
204 (138-272)
5-2 (3-3—16-5) 
709 (450-917) 
1201 (559-2867)
6-4 (3-4-10-3) 
1-3 (0-9-2-4) 
13-8 (5-9-39-9)
1-4 (0-8-2-3) 
120 (96-172)*
2-6 (1-4-5-5) 
381 (290-567) 
350 (193-594)*
Values are median (95 per cent confidence interval). tPA, 
Tissue-type plasminogen activator; PAI, plasminogen activator 
inhibitor; uPA, urokinase-type plasminogen activator; TAT, 
thrombin-antithrombin III; PAP, plasmin-a2-antiplasmin. 
*P <  005  (patients with peritonitis versus controls, Mann- 
Whitney U test)
Statistical analysis
4 -
Data are expressed as median values and 95 per cent confidence 
intervals. The Mann-Whitney U test was used for analysis of 
differences between groups. Correlations between plasma and 
peritoneal fluid values were analysed by Spearman’s rank test. 
jP< 0*05 was considered significant.
Results
Activation of coagulation in the abdominal exudate of 
patients with peritonitis was demonstrated by significantly
TAT complex concentrations, compared with 
controls (Table 1). Stimulation of the fibrinolytic system in 
the peritoneal fluid of patients with peritonitis was 
demonstrated by significantly raised levels of tPA, uPA, 
PAP complex and fibrin degradation products, compared 
with those found in the peritoneal fluid of controls (Table 
1). Median peritoneal fluid concentrations of tPA and 
uPA in patients with peritonitis were about 65- and 
tenfold respectively higher than values in controls. PAI-1 
antigen showed an 800-fold increase. Hence, concen­
trations of PAP complex and fibrin degradation products in 
the peritoneal fluid of patients with peritonitis were 
significantly raised in comparison with those in controls.
By contrast, plasma concentrations of TAT and PAP 
complex, and tPA and PAI-1 antigen and activity, were 
comparable in patients with and without peritonitis. Only
degradation products in patients with peritonitis were 
higher than those in control patients (Table 2).
Neither in those with peritonitis nor in control patients 
did the level of any coagulation or fibrinolytic factor 
measured in the plasma correlate with that observed in 
the peritoneal fluid.
Discussion
This study demonstrates that, in the abdominal cavity of 
patients with bacterial peritonitis, both the coagulation 
cascade and the fibrinolytic system are stimulated. The 
resultant deposition of fibrin probably reflects a relative 
deficit of fibrinolytic activity, resulting from strongly 
enhanced inhibition of plasminogen activators.
The markedly raised concentration of TAT complex in 
the peritoneal fluid of all patients with peritonitis 
demonstrates intraperitoneal stimulation of coagulation. 
The coagulation cascade may be triggered by expression 
of tissue factor (procoagulant activity) on injured méso­
thélial and endothelial cells in the peritoneum13-15 and on 
peritoneal macrophages, which express tissue factor 
following stimulation with, for example, endotoxin and 
tumour necrosis factor (TNF)15,16. The relative 
contribution of separate cell types to intra-abdominal 
coagulation has not yet been clarified. It seems that 
activation of coagulation was confined to the abdominal 
cavity, as the plasma TAT complex concentration in most 
patients with peritonitis was not raised. In a few patients 
with sepsis, high plasma levels of TAT complex were 
found, which is in concordance with earlier reports on the
sepsis and systemic hyper-
plasma concentrations uPA antigen and fibrin
relationship between 
coagulability17’18.
These data show increased levels of fibrinolytic 
activators following peritonitis. This finding is in 
agreement with that of Dorr et al, ll), who reported 
increased fibrinolytic activity and fibrin degradation in the 
peritoneal fluid of women with pelvic inflammatory 
disease. Increased tPA antigen levels in the peritoneal 
fluid, associated with normal plasma levels of tPA antigen 
in patients with bacterial peritonitis, suggest local 
production of tPA. In particular, mesothelial cells and 
submesothelial endothelium might be responsible for the 
production of tPA20,21. The increased tPA concentrations 
found in the present study might be explained by prompt 
release from a preformed storage pool within these cells. 
Several ‘stress factors’ and inflammatory mediators, 
stimulated by bacterial infection, may induce such a 
release of tPA in vivo22. However, these findings are not 
supported by in vitro experiments in which inflammatory
© 1996 Blackwell Science Ltd, British Journal o f  Surgery 1996, 83, 1133-1135
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stimuli, such as T N F  and interleukin tPA
release by cultured m ésothélia l and endothelia l cells21-21. 
Alternatively, increased levels o f  tP A  might be caused by 
leakage from m ésothélia l cells, which are dam aged during 
peritoneal infection.
PAI-1 form s a ‘on e  to  o n e ’ inactive com plex with both  
tPA and uPA. B ecause the increase in PAI-1 con cen ­
tration in the peritoneal fluid o f  patients with peritonitis 
was much higher than that o f  tP A  and uPA, com plete
inhibition o f  fibrinolytic activity in the abdominal cavity
might be H ow ever , plasm in activity has
occurred, as shown by the raised levels o f  PA P com plex
and fibrin degradation A s plasm inogen
activation, m ediated by tPA , is significantly enhanced in 
the presence o f  fibrin, tP A  may display fibrinolytic effects  
even in the presence o f  a high PAI-1 level24 "5.
The rise o f  uP A  in the peritoneal fluid o f  patients with 
peritonitis is probably not linked to  m ésothélium , but to
uPA has not 
mésothélial, but in endothelia l,  
inflamed appendices and in in vitro cultures,
inflam m atory cytokines26,27.stimulation with mes-" - /  The more
increase in uPA  levels in peritoneal fluid, 
compared with that in plasm a, might be explained by the 
direction o f  secreting u P A  by endothelia l cells, which is 
mainly ablum inal27. E xcept for a relatively small increase 
in uPA and fibrin degradation  products concentrations, 
plasma levels were not raised in patients with peritonitis. 
Based on the findings o f  predom inantly normal plasma
o f  correlation betw eenlevels, as well as the 
plasma and peritoneal fluid levels, the authors hypothesize  
that the abdom inal cavity with its surrounding peritoneum  
acts as a separate com partm ent. T he coagulation and
fibrinolytic to bacterial peritonitis in this
compartment, and the system ic effects, depend on many  
factors, o f  which individual contributions are difficult to 
assess. It seem s that the increase in fibrinolytic activity 
during peritonitis is lim ited by high PAI-1 levels, and does  
not m eet the overw helm ing dem and to overcom e fibrin
References
1 s. I.
1
DII, Simmons RL. Fibrin in 
Beneficial and adverse effects of fibrin in experimental E. coli 
peritonitis. Surgeiy 1980; 88: 41-7.
3
4
5
it 9
6
7
8
, Girotti MJ, Glynn MFX, Goldberg JM, 
Rotstein OD. Effect of systemic fibrinogen depletion on 
intraabdominal abscess formation../ I.ah Clin Med 1991; 118:
48-55.
Fry DE, Garrison RN, Heitseli RC\ Calhoun K, Polk 11C Jr.
.‘rm¡mints of death in patients with intra-abdominal 
abscess. Surgery 1980; 88: 517-23.
5 A, Davis NL, Robins RE. Surgical versus 
percutaneous drainage of intra-abdominal abscesses. Am J
Sure 1991; 161: 593-5.
Hau T, Payne WD, Simmons RL. Fibrinolytic aelivily of the 
peritoneum during experimental peritonitis. Surg Gvnecol 
Obstet 1979; 148: 415-18.
van Goor I I, de Graaf JS, Grond J et al. Fibrinolytic activity 
in the abdominal cavity of rats with faecal peritonitis. Br J 
Surg 1994; 81: 1046-9.
Vipond MN, Whawell SA, Thompson JN, Dudley IIAF.
of experimental peritonitis and ischaemia on 
peritoneal fibrinolytic activity. EurJ Surg 1994; 160: 471-7, 
Vipond MN, Whawell SA, Thompson JN,
Peritoneal fibrinolytic activity and intra-abdominal adhesions. 
Lancet ; 335: 1120
9 Ranby M, Sundell IB, Nilsson TK. Blood collection in strong 
acidic citrate anticoagulant used in a study of dietary 
influence on basal tPA activity. Thromb Haemost 1989; 62: 
9 1 7  - 2 2 .
10 Nilsson K, Rosén S, Friberger P. A  new kit for the 
determination of tissue plasminogen activator and its 
inhibitor in blood. Fibrinolysis 1987; 1: 163-8.
11 Stief TW, Lenz P, Becker U, Heimburger N. Determination 
of plasminogen activator inhibitor (PAI) capacity of human 
plasma in presence of oxidants: a novel principle. Thromb Res 
1988; 50: 559-73.
12 Binnema DJ, van Iersel JL, Dooijewaard G. Quantitation of 
urokinase antigen in plasma and culture media by use of a 
ELISA. Thromb Res 1986; 43: 569-77.
Bevilacqua, MP, Pober JS, Majeau GR, Fiers W, Cotran RS, 
Gimbrone MA Jr. Recombinant tumor necrosis factor
13
14
in cultured human vascular 
endothelium: characterization and comparison with 
actions of interleukin 1. Proc Natl Acad Sci U S A 1986; 83:
4533-7.
Drake TA, Morrisey JH, Edgington TS. Selective cellular 
expression of tissue factor in human tissues. Implications for
rs of hemostasis and thrombosis. Am  J Pathol 1989;
134: 1087-97.
15 Sinclair SB, Rotstein OD, Levy GA. Disparate mechanisms 
of induction of procoagulant activity by live and inactivated 
bacteria and viruses. Infect Immun 1990; 58: 1821-7.
16 Chapman HA Jr, Vavrin Z, I-Iibbs JB Jr. Coordinate
of macrophage procoagulant and fibrinolytic
activity in vitro and in vivo. J Immunol 1983; 130: 261-6.
17 Smith-Erichsert N, Aasen AO, Gallimore MJ, Amundsen E. 
Studies of components of the coagulation system in normal 
individuals and septic shock patients. Circ Shock 1982; 9: 
491-7.
18 Okamoto K, Takaki A, Takeda S, Katoh H, Ohsato K. 
Coagulopathy in disseminated intravascular coagulation due 
to abdominal sepsis: determination of prothrombin fragment 
1 + 2 and other markers. Haemostasis 1992; 22: 17-24.
19 Dörr PJ, Brommer EJP, Dooijewaard G, Vemer HM. 
Peritoneal fluid and plasma fibrinolytic activity in women 
with pelvic inflammatory disease. Thromb Haemost 1992; 68:
102-5.
20
o I
.1.
Rijken DC, Wijngaards G, Welbergen J. Immunological 
characterization of plasminogen activator activities in human 
tissues and body fluids, J Lab Clin Med 1981; 97: 477-86. 
van Hinsbergh VWM, Kooistra T, Scheffer MA, van Bockel
van Muijen GNP. Characterization and fibrinolytic 
’rties of human omental tissue mesothelial
Comparison with endothelial cells. Blood 1990; 75: 1490-7.
PC, Parrillo JE. Promotion andar
subsequent inhibition of plasminogen activation after
administration of intravenous endotoxin to normal subjects. 
N Engl J Med 1989; 320: 1165-72.
23 Bevilacqua MP, Schleef RR, Gimbrone MA Jr, Loskutoff DJ.
' « m a t t o n of the fibrinolytic of cultured human
vascular endothelium by interleukin 1../ Clin invest 1986; 78:
587-91.
24 Iloylacrts M, Rijken DC', Lijnen HR, Collen D. Kinetics of 
the activation of plasminogen by human tissue plasminogen 
activator. Role of fibrin. J Biol Chem 1982; 257: 2912-19.
25 Colluci M, Paramo JA, Stassen JM, Collen I). Influence of 
the last-acting inhibitor of plasminogen activator on in vivo 
thrombolysis induced by tissue-type plasminogen activator in
s. J CliU U  t  A )i J k ----------------
26
f c
Invest 1986; 78: 138-44.
Gr0ndahl-IIansen J, Kirkeby LT, Ralfkuier E, Kristensen P, 
Lund LR, Dano K. Urokinase-type plasminogen activator in 
endothelial cells during acute inflammation of the appendix. 
J Patlwl 1989; 135: 631-6.
EA, Fiers W,11 van
factor
VWM, van den 
Dooijewaard G. Tumor necrosis 
production of urokinase-type 
human endothelial cells. Blood 1990; 75: 1991-8.
activator by
1996 Blackwell Science Ltd, British Journal of Surgery 1996, 83, 1133-1135
